Insider Cluster (5 insiders) ·Filed Jun 15, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago
Insider cluster: 5 insiders, $0.4M total
Actionable Insight • Neutral

The selling is modest and likely liquidity-driven. Monitor for any upcoming corporate events (e.g., pipeline milestones or earnings) that could explain the timing, but this cluster does not warrant a defensive trade on its own.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
ABEO ▲ +24.96% at T+20d
NEUTRAL call ✓ call won +24.96% · α vs SPY +24.76% · entry $5.65 → $7.06
Next anchor: T+60d due 22d ago
Latest observation: T+57 +8.42% FF3 residual α
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α +1.25%
$5.65
settled 4mo ago
T+5d
+1.24%
call +1.24% · α +3.47%
$5.72
settled 3mo ago
T+20d
+24.96%
call +24.96% · α +24.76%
$7.06
settled 3mo ago
T+60d
—
call — · α —
—
due 22d ago

Price Chart

Loading chart...

Executive Summary

Five ABEO insiders, including the CEO and CFO, sold a total of $407K in shares over a 7-day window. The selling represents 0.13% of market cap, a modest amount that is typical of routine diversification or liquidity needs rather than a strong negative signal.

Key Financial Metrics

Direction
selling
Total Value
$407.0K
Insiders
5

Key Facts

  • CEO Vishwas Seshadri sold 31.9K shares ($169K) on June 9.
  • CFO Joseph Vazzano sold 13.4K shares ($71K) on June 9.
  • Director Christine Silverstein sold 18.2K shares ($104K) on June 15.
  • Total insider sales of $407K represent 0.13% of ABEO's $322M market cap.
  • All sales were open-market transactions; no 10b5-1 plan disclosures are noted.

Financial Impact

Insider sales of $407K total, modest relative to $322M market cap (0.13%).

Risk Factors

  • Insider selling could accelerate if negative news emerges.
  • Biotech sector volatility may amplify any sentiment shift.
  • Further selling from C-suite could signal waning confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABEO-1781728397497
19 reports for ABEO
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +3.70%Aug 14, 2026
Filters
Rows
Reports for ABEO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$5.47 $5.57▲ +1.83%▲ +1.01%$5.03 (−8.14%)
Aug 14, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$5.94 $6.06▲ +2.02%▲ +3.21%$5.03 (−15.40%)
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Aug 13, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.98 $7.02▲ +0.57%▲ +1.13%$5.03 (−28.01%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$5.65 $5.72▲ +1.24%▲ +3.47%$5.03 (−11.06%)
Jun 15, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$5.65 $5.72▼ −1.24%▼ −3.47%$5.03 (+11.06%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.77▲ +4.34%▲ +3.67%$5.03 (−9.13%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.65▲ +2.17%▲ +1.74%$5.03 (−9.13%)
Jun 10, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.36 $5.65▼ −5.41%▼ −1.98%$5.03 (+6.25%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 17, 2026